Skip to main content

Peripheral Arterial Disease Videos

Dr Anahita Dua speaks at AMP 2026
AMP 2026
09/10/2026
Anahita Dua, MD, MS, MBA, FACS
Dr Anahita Dua discusses the changing face of CLTI.
Dr Anahita Dua discusses the changing face of CLTI.
Dr Anahita Dua discusses the...
09/10/2026
Vascular Disease Management
Dr N'Dandu speaks at AMP 2026
AMP 2026
09/01/2026
Zola N'Dandu, MD
Dr Zola N'Dandu discusses the woundosome concept and its impact on outcomes in patients with chronic limb-threatening ischemia.
Dr Zola N'Dandu discusses the woundosome concept and its impact on outcomes in patients with chronic limb-threatening ischemia.
Dr Zola N'Dandu discusses the...
09/01/2026
Vascular Disease Management
Marianne Brodmann, MD, speaks at AMP 2026.
AMP 2026
08/25/2026
Marianne Brodmann, MD
Dr Marianne Brodmann discusses the latest results from the DEEPER OUS trial.
Dr Marianne Brodmann discusses the latest results from the DEEPER OUS trial.
Dr Marianne Brodmann discusses...
08/25/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Dr Marianne Brodmann speaks at ISET 2026
ISET 2026
03/12/2026
Marianne Brodmann, MD
Dr. Brodmann reviews the results of the TRUE-PTX study, which compared paclitaxel drug-eluting and bare device treatment for PAD using real-world data design.
Dr. Brodmann reviews the results of the TRUE-PTX study, which compared paclitaxel drug-eluting and bare device treatment for PAD using real-world data design.
Dr. Brodmann reviews the results...
03/12/2026
Vascular Disease Management